/EXAI

EXAI Stock - Exscientia plc

Q: What is the analyst price target for EXAI?

Analyst price target information is not currently available for EXAI.

Q: What is EXAI's market cap?

Market capitalization information is not currently available for EXAI.

Healthcare|Biotechnology|NASDAQ

$4.84+0.00%

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+3.3%upside

Target: $5.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for EXAI

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

FY2022

FY2023

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.83

52W High$4.84

52W Low$4.84

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	$20.08M	$26.82M	$20.32M	$13.18M	$11.94M
Gross Profit	$-7,324,000	$-5,950,923.5	$7.63M	$-6,206,304	$4.55M
Gross Margin	-36.5%	-22.2%	37.6%	-47.1%	38.1%
Operating Income	$-176,004,000	$-142,985,203	$-41,357,850	$-31,602,545.757	$-9,705,249.908
Net Income	$-145,963,000	$-116,735,924	$-36,524,529	$-30,367,826.431	$-8,282,634.919
Net Margin	-726.9%	-435.3%	-179.7%	-230.4%	-69.4%
EPS	$-1.18	$-0.96	$-0.30	$-0.25	$-0.07

Company Overview

Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.

Visit Website

Rating Distribution

Strong Buy

Buy / Outperform

50%

Hold / Neutral

50%

Sell / Underperform

Analyst Consensus🟡 Mixed

1 Bullish1 Neutral/Bearish

Price Targets

Average Target

↑ 86.0% Upside

Now

Low

Average

High

Based on 1 analyst

Recent Analyst Actions

Date	Firm	Action	Rating	Price Target
July 9th 2024	TD Cowen	Initiation	Buy	-
January 5th 2024	BofA Securities	Downgrade	Neutral	$9← $11

Earnings History & Surprises

EXAI

Beat Rate

46%

Last 13 quarters

Avg Surprise

-108.6%

EPS vs Estimate

Beats / Misses

6/7

Last 12 quarters

Latest EPS

$-0.52

Q4 2024

EPS Surprise History

Q1 23

-215.2%

$-0.38vs$0.33

Q2 23

-188.4%

$-0.38vs$0.43

Q3 23

+9.8%

$-0.37vs$-0.41

Q4 23

+22.5%

$-0.31vs$-0.40

Q1 24

+4.5%

$-0.42vs$-0.44

Q2 24

+25.0%

$-0.21vs$-0.28

Q3 24

-16.1%

$-0.36vs$-0.31

Q4 24

-477.8%

$-0.52vs$-0.09

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2024	Nov 8, 2024	$-0.09	$-0.52	-477.8%	✗ MISS
Q3 2024	Aug 15, 2024	$-0.31	$-0.36	-16.1%	✗ MISS
Q2 2024	May 21, 2024	$-0.28	$-0.21	+25.0%	✓ BEAT
Q1 2024	Mar 21, 2024	$-0.44	$-0.42	+4.5%	✓ BEAT
Q4 2023	Nov 9, 2023	$-0.40	$-0.31	+22.5%	✓ BEAT
Q3 2023	Aug 10, 2023	$-0.41	$-0.37	+9.8%	✓ BEAT
Q2 2023	May 24, 2023	$0.43	$-0.38	-188.4%	✗ MISS
Q1 2023	Mar 23, 2023	$0.33	$-0.38	-215.2%	✗ MISS
Q4 2022	Nov 15, 2022	$-0.22	$-0.32	-45.5%	✗ MISS
Q3 2022	Aug 17, 2022	$-13.61	$-0.29	+97.9%	✓ BEAT
Q2 2022	May 25, 2022	$-0.31	$-0.41	-32.3%	✗ MISS
Q1 2022	Mar 23, 2022	$-0.12	$-0.91	-658.3%	✗ MISS
Q4 2021	Nov 17, 2021	$-0.21	$-0.08	+61.9%	✓ BEAT
Q4 2021	Oct 4, 2021	—	$-0.30	—	—
Q1 2021	Mar 31, 2021	—	$-0.09	—	—
Q4 2020	Dec 31, 2020	—	$-0.12	—	—
Q3 2020	Sep 30, 2020	—	$-0.12	—	—
Q2 2020	Jun 30, 2020	—	$-0.06	—	—
Q1 2020	Mar 31, 2020	—	$-0.06	—	—
Q4 2019	Dec 31, 2019	—	$-0.01	—	—